Thermo Fisher Shells Out $876M For Viral Vector Maker
Lab equipment supplier Thermo Fisher said Friday that it coughed up €725 million ($876 million) in cash to purchase Henogen — a company that makes viral vectors to deliver genetic material...To view the full article, register now.
Already a subscriber? Click here to view full article